Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
The improvement of drugs and protocols of chemotherapeutic treatment has led to improved outcomes and survival in patients with cancer. But along with this, at first glance a positive point, there was another interdisciplinary problem, which is the need for early detection and treatment of developin...
Main Authors: | A. M. Chaulin, D. V. Duplyakov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2022-03-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2663 |
Similar Items
-
The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014-02-01) -
Cardioprotective effect of thiotriazoline in cancer patients
by: A. V. Koltsov, et al.
Published: (2023-02-01) -
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
by: Jacqueline T. Vuong, et al.
Published: (2022-04-01) -
Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines
by: Aditi A. Bhagat, et al.
Published: (2023-12-01) -
Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)